Last update Sept. 18, 2022

Adenosine Triphosphate (ATP)

Compatible

Safe product and/or breastfeeding is the best option.

Adenosine triphosphate (ATP) is an endogenous adenine nucleotide present in all cells of the body. It is a vasodilator that has been used in cerebral and peripheral vascular disorders and also in the treatment of supraventricular tachycardias (adenosine is preferred). Intravenous administration.

Since the last update we have not found published data on its excretion in breastmilk.

It is rapidly metabolized to adenosine diphosphate (ADP). Its plasma half-life is so short (< 10 seconds) that it is highly unlikely that any of the drug will pass into breast milk. (Hale, Briggs 2015, Tan 2001)

Furthermore, its null oral bioavailability prevents the passage to the infant's plasma from ingested breast milk.

There is no evidence for the efficacy of PTA for other indications such as low back pain. (Bannwarth 2005)

Alternatives

We do not have alternatives for Adenosine Triphosphate (ATP) since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

Adenosine Triphosphate (ATP) is also known as


Adenosine Triphosphate (ATP) in other languages or writings:

Group

Adenosine Triphosphate (ATP) belongs to this group or family:

Tradenames

Main tradenames from several countries containing Adenosine Triphosphate (ATP) in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 0 %
Molecular weight 507 daltons
Tmax 0.0002 - 0.003 hours

References

  1. AEMPS. Adenosina trifosfato. Ficha técnica. 2020 Full text (in our servers)
  2. Bannwarth B, Allaert FA, Avouac B, Rossignol M, Rozenberg S, Valat JP. A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain. J Rheumatol. 2005 Jun;32(6):1114-7. Abstract

Total visits

10,557

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM